Close
ACHEMA MIDDLE EAST 2026

Afrezza – Mealtime Insulin Therapy for Diabetes

Afrezza is a rapid-acting insulin therapy indicated for controlling hyperglycaemia in adult patients with type 1 and type 2 diabetes mellitus. The drug is...

Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes

Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics. The drug was discovered...

Arzerra (Ofatumumab) for Treatment of Chronic Lymphocytic Leukaemia (CLL)

Arzerra (ofatumumab) is the first-line drug approved for the treatment of chronic lymphocytic leukaemia (CLL). The drug is developed and marketed by GlaxoSmithKline (GSK)...

Roche Vitamin Plant

Roche's latest vitamin plant is located in Taishan (Shanghai) which is in the north eastern part of the Peoples' Republic of China. Roche Holding...

AstraZeneca Solid Forms Production Plant

AstraZeneca's pharmaceutical production facility in Sixth of October City (Madinat Sittah Uktubar), near Cairo, produces a broad range of the company's product portfolio including...

Cipra Medpro Ltd

Cipla Medpro Pharmaceuticals is listed on the Johannesburg Securities Exchange and is one of South Africa's top ten and fastest-growing pharmaceutical groups. Formerly known...

GSK’s New Biopharmaceutical Plant

GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK in February 2014. The new facility will be located...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...